SCHEMBL22739749

SCHEMBL22739749

CCCCCc1cc(O)c(C/C=C/CCC=C(C)C)c(O)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.70
CNR2 P34972 3/20 0.70
TRPV1 Q8NER1 3/20 0.70
SLC6A3 Q01959 3/20 0.70
TRPA1 O75762 2/20 0.70
SLC6A2 P23975 2/20 0.70
SLC6A4 P31645 2/20 0.70
TRPM8 Q7Z2W7 2/20 0.70
TRPV3 Q8NET8 2/20 0.70
TRPV4 Q9HBA0 2/20 0.70
TRPV2 Q9Y5S1 2/20 0.70
INHA P05111 1/20 0.70
HTR2A P28223 1/20 0.70
OPRM1 P35372 1/20 0.70
PPARG P37231 1/20 0.70
KCNH2 Q12809 1/20 0.70
CYP19A1 P11511 1/20 0.55
NPC1 O15118 1/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9029687 0.85 CNR1 (0.76) CNR1CNR2TRPV1SLC6A3TRPA1
Cannabigerol SCHEMBL144819 0.82 PPARG (1.00) CNR1CNR2TRPV1SLC6A3TRPA1
Cannabigerol SCHEMBL14764730 0.82 PPARG (1.00) CNR1CNR2TRPV1SLC6A3TRPA1
Cannabigerol SCHEMBL12954626 0.82 PPARG (1.00) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23523042 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23523454 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23523040 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23523543 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23522965 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1
SCHEMBL23522969 0.81 PPARG (0.97) CNR1CNR2TRPV1SLC6A3TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218624-A1 INCLUSION COMPOUND CONTAINING NON-PSYCHOACTIVE CANNABINOID AND METHOD FOR PREPARTION THEREOF HANYI BIO-TECHNOLOGY (BEIJING) CO., LTD. (CN) 2022-07-14 US disclosed
EP-3978007-A1 INCLUSION COMPOUND CONTAINING NON-PSYCHOACTIVE CANNABINOID AND METHOD FOR PREPARATION THEREOF Hanyi Biotechnology (Beijing) Co., Ltd. (CN) 2022-04-06 EP disclosed
WO-2020238642-A1 INCLUSION COMPOUND CONTAINING NON-PSYCHOACTIVE CANNABINOID AND METHOD FOR PREPARATION THEREOF 汉义生物科技(北京)有限公司 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218624-A1 INCLUSION COMPOUND CONTAINING NON-PSYCHOACTIVE CANNABINOID AND METHOD FOR PREPARTION THEREOF CNR2, CNR1, CACNG8 CNR1 2/4885CNR2 1/4885TRPV1 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.